3-Quinolinecarboxylic acid, 1-cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- - Names and Identifiers
Name | 8-Ethoxymoxifloxacin
|
Synonyms | 8-Ethoxymoxifloxacin Moxifloxacin EP Impurity C Moxifloxacin IMpurity C (EP) Moxifloxacin related substance C Moxifloxacin EP Impurity C Hydrochloride 1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid 1-Cyclopropyl-8-ethoxy-6-fluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-8-ethoxy-6-fluoro-4-oxo-quinoline-3-carboxylic acid
|
CAS | 1029364-75-7
|
InChI | InChI=1/C22H26FN3O4/c1-2-30-21-18-14(20(27)15(22(28)29)10-26(18)13-5-6-13)8-16(23)19(21)25-9-12-4-3-7-24-17(12)11-25/h8,10,12-13,17,24H,2-7,9,11H2,1H3,(H,28,29)/t12-,17+/m0/s1 |
3-Quinolinecarboxylic acid, 1-cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- - Physico-chemical Properties
Molecular Formula | C22H26FN3O4
|
Molar Mass | 415.46 |
Density | 1.377±0.06 g/cm3(Predicted) |
Boling Point | 641.8±55.0 °C(Predicted) |
pKa | 6.44±0.50(Predicted) |
Storage Condition | 2-8℃ |
3-Quinolinecarboxylic acid, 1-cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- - Risk and Safety
Safety Description | 24/25 - Avoid contact with skin and eyes.
|
HS Code | 29339900 |
3-Quinolinecarboxylic acid, 1-cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- - Introduction
Moxifloxacin EP Impurity C, the chemical name is 5-hydroxymethylmoxifloxacin, is an impurity of moxifloxacin. The following is a description of its nature, use, formulation and safety information:
Nature:
Moxifloxacin EP Impurity C is white or off-white crystalline powder, soluble in some organic solvents, such as methanol and acetonitrile. It is stable in air, but not in acidic or alkaline conditions.
Use:
Moxifloxacin EP Impurity C is mainly used as a reference standard in pharmaceutical research and analysis. It can be used to evaluate and determine the content of impurities in moxifloxacin preparations and their quality.
Preparation Method:
Moxifloxacin EP Impurity C is usually prepared by chemical synthesis. The specific preparation method requires special experimental conditions and technical requirements, which generally need to be carried out in the laboratory or industrial production research and development.
Safety Information:
Regarding the safety information of moxifloxacin EP impurity C, because its use is mainly used in laboratories and research, its safety is relatively high. However, for any chemical substances, it is still necessary to take appropriate safety measures, including wearing appropriate protective equipment (such as gloves and glasses) and avoiding direct exposure to the skin or inhalation of its dust during handling. If handling or storage of this chemical is required, it is recommended to refer to the relevant safety data sheets and operating manuals and to follow the correct laboratory specifications and guidelines. In addition, moxifloxacin EP impurity C should be kept away from children and pets, properly stored in a dry, cool, ventilated place. If there is any doubt or unexpected situation, you should immediately seek professional help.
Last Update:2024-04-09 21:54:55